Go to SC301 Clinic AI Consultation Request
Sollea AI Consultation
Sollea AI Consultation
Go to SC301 Clinic AI Consultation Request
Skip to main content
svf-breast

The high average engraftment rate of 77.48% is due to excellent extraction technology and
This is a result that becomes possible only when supported by independent research data.

SC301 Clinic Representative Director Shin Dong-jin SVF Breast Augmentation Third Philosophy Image
author avatar
SC301 Clinic Shin Dong Jin - Representative Director / Chief Medical Director
We pursue sustainable beauty for women based on sound thinking and sound research. SC301 was the first in Korea to introduce stem cell breast augmentation. We adhere to the promise of a stem cell master: a principle of performing no more than three surgeries per day. As a leader in stem cells, we conduct ceaseless research based on over 19 years of surgical experience and more than 9,000 cases.